Life Sciences Research Partners V.Z.W. is the famous VC, which was founded in 1988.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2015. The high activity for fund was in 2013.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Medical Device. Among the various public portfolio startups of the fund, we may underline Bone Therapeutics, Celyad The fund has exact preference in a number of founders of portfolio startups.
The overall number of key employees were 1.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Life Sciences Research Partners V.Z.W., startups are often financed by S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are Nausicaa Ventures, Hunza Ventures, Grifols. In the next rounds fund is usually obtained by Hunza Ventures, Grifols.
Related Funds
| Fund Name | Location |
| Aescuvest | Frankfurt, Germany, Hessen |
| AIMCo | Colorado, Denver, United States |
| Bayer Global Investments | - |
| Boussard & Gavaudan Holding | England, London, United Kingdom |
| Dynamic Venture Opportunities Fund | Canada, Ontario, Toronto |
| Endicott Group | New York, New York, United States |
| Future Capital | Frankfurt, Germany, Hessen |
| Heritage Medical Center | - |
| iloom | Seoul, Seoul-t'ukpyolsi, South Korea |
| JUNQUANXIN Capital | Changning, China, Shanghai |
| Karnataka Trustee | - |
| NHS England | Redditch, United Kingdom, Worcestershire |
| Octahedron Capital | California, San Francisco, United States |
| SEI | SEI Ventures (NASDAQ: SEIC) | Oaks, Pennsylvania, United States |
| Shanghai Fangyu Touzi Guanli Zhongxin | China, Shanghai |
| Shenzhen Xiande Investment Holdings | China, Guangdong, Shenzhen |
| Tribune Digital Ventures | California, Palo Alto, United States |
| Waterloo Capital | Atlanta, Georgia, United States |
| Yellowwoods | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ITeos Therapeutics | $10M | 03 May 2012 | Cambridge, Massachusetts, United States | ||
Celyad | $8M | 19 Jan 2009 | Walloon Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ITeos Therapeutics | $10M | 03 May 2012 | Cambridge, Massachusetts, United States | ||
Celyad | $8M | 19 Jan 2009 | Walloon Brabant |
